This research formulation contains a combination of the amylin analog Cagrilintide and a GLP-1 receptor agonist. It is intended for in vitro studies investigating the synergistic or additive interactions between these two distinct molecules on cellular signaling pathways in controlled laboratory models.

Key Specifications:

ICN: 4-0336-0084
Alias: Cagrilintide / GLP-1
Strength: 8.4mg/7mg
Purity: >99%

Storage Instructions:
Store in a cool, dry place at -20°C for long-term storage, or 2-8°C for short-term storage. Protect from light. Reconstituted solutions should be stored under sterile conditions at 2-8°C and used within 28 days.

Disclaimer:
For research use only. Not for human or veterinary use. Not for consumption or therapeutic application.